EPITACT® SPORT is a new brand from the French laboratory MILLET Innovation, a leader in podiatry products in Europe with its brand EPITACT®. The company has developed a unique range of protections and orthoses for various sports activities such as running, hiking, skiing, football, tennis, rugby, basketball, and cycling, among others, thanks to their breakthrough technologies and global patents.
EPITACT® SPORT's products are ultra-thin and ultra-light, specifically designed for both amateur and professional athletes. The product line currently includes a proprioceptive patellar knee brace, plantar protections, corrective orthoses for hallux valgus, protection against blue nails and blisters, solutions for shin and ankle pain, and more products in the pipeline.
The company's GENOUILLÈRE FLEX01, weighing less than 60g, has been hailed as a true revolution in orthopedics. The silicone maintenance tendon combined with compression fabric enhances patellar support and knee stability without restricting movement or causing discomfort. The knee brace has garnered praise from sports specialists and is recommended by healthcare professionals. It is available in pharmacies.
With a foundation year dating back to 1998, EPITACT® SPORT operates in the Consumer Goods and Manufacturing industries. Though the exact headquarters location and recent investment details are not provided, the innovative product range and the company's reputation among athletes and healthcare providers make it an intriguing potential investment opportunity for venture capitalists looking to support innovative solutions in the sports and healthcare sectors.
There is no investment information
No recent news or press coverage available for EPITACT® SPORT.
We care about your data, and we'd love to use cookies make your experience better.
